Yale Psychedelic Science Group

Yale Psychedelic Science Group Logo

With the recent re-emergence of psychedelic research demonstrating therapeutic efficacy for a variety of psychiatric and medical conditions, a small group of residents, fellows and faculty at Yale that initially met informally to discuss current research recognized the need for a more structured educational initiative to illuminate this important and rapidly growing area of science. Consequently, the Yale Psychedelic Science Group (YPSG) was established in January 2016 as an interest group within the Yale Department of Psychiatry to discuss issues at the intersection of psychedelic substances and psychiatry.

Although the YPSG hopes to enlarge the scope of its discussion and activities, its initial focus will be on contemporary clinical research and the mechanisms of action of psychedelic treatments. Therefore, the YPSG has organized a forum where clinicians and scholars from across Yale can learn about and discuss recent studies in an academically rigorous manner. At our monthly meetings, research scientists from outside institutions who are actively engaged in clinical studies with classical psychedelic compounds will present their findings. The primary objectives of this forum are to promote a critical examination of the presented work and to encourage the sharing of interdisciplinary perspectives during the ensuing discussion period.

Members of the YPSG organizing committee can be reached at yalepsg@gmail.com. You may subscribe, unsubscribe or edit your subscription to the YPSG email listserv by visiting http://mailman.yale.edu/mailman/listinfo/yalepsych

YPSG Events Listing

Upcoming Events

December 13, 2017 - 6:30-8:00 pm in The Fulton Room - Mason Marks, MD, JD, Visiting Fellow, Yale Law School, Information Society Project.

Title - "Legal Barriers to Research on Schedule I Controlled Substances"

Fall 2017

November 29, 2017 - Brian D. Earp, MSc (Oxford), MPhil (Cambridge), Associate Director, The Yale-Hastings Program in Ethics and Health Policy, Yale University and The Hastings Center.

Title - "Pioneering Training in Psychedelic Therapy: The Experience of CHS and Future Directions"

October 23, 2017 - Tyler Gage, Co-founding partner and strategic advisor to NAKU, a healing center run by the Sapara people in the Ecuadorian Amazon.

Title - "Plant Medicine Meets Biomedicine: Creating Integrated Healing Centers in the Amazon"

Spring 2017

February 7, 2017 - Franz X. Vollenweider, DR., MD, FMH Psych., Director Center for Psychiatric Research, Department of Psychiatry, Psychotherapy, and Psychosomatics, University of Zürich.

Title - "The Neurobiology of Psychedelic Drugs: Implications for the Treatment of Mood Disorders"


March 7, 2017 - Janis Phelps, Ph.D., professor at the California Institute of Integral Studies (CIIS), Director of the CIIS Center for Psychedelic Therapies and Research.

Title - "Pioneering Training in Psychedelic Therapy: The Experience of CIIS and Future Directions"

Fall 2016

September 20, 2016 - Jeffrey Guss, MD, Assistant Professor of Psychiatry, New York University

Title - "Psychedelic Therapy: A Treatment in Search of a Disorder"


October 6, 2016 - Bia Labate, PhD, Visiting Professor at the Center for Research and Post Graduate Studies in Social Anthropology (CIESAS) in Guadalajara, Mexico

Title - "Ayahuasca and Health: An Overview of Medical and Social Science Research"


October 11, 2016 - Alicia Danforth, PhD, Clinical Psychologist and Researcher, Los Angeles Biomedical Research Institute at the Harbor-UCLA Medical Center

Title - "MDMA-assisted Therapy for Social Anxiety in Autistic Adults"


November 8, 2016 - Katherine MacLean, PhD, Research Scientist and Co-founder/Director of the Psychedelic Education and Continuing Care program in New York City

Topic - "Measuring the Mystical Experience, Integration of Psychedelic Treatment"


December 13, 2016 - Katrin Preller, PhD, Postdoctoral Fellow at the University of Zurich, Department of Psychiatry

Topic - "fMRI/EEG Studies Investigating the Pharmacological and Neural Correlates of Altered States of Consciousness"

Spring 2016

January 19, 2016 - Peter H. Addy, PhD, Yale Associate Research Scientist in Anesthesiology, VA Connecticut Health Care System

Title - "Inaugural Session: Historical And Current Perspectives On Psychedelic Research"


February 9, 2016 - Albert Garcia-Romeo, MD, Research Associate in Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine

Title - "Psilocybin in the Treatment of Smoking Addiction: Psychological Mechanisms and Participant Accounts"


March 8, 2016 - Tehseen Noorani, PhD, visiting scholar in Anthropology at the New York School for Social Research

Title - "Psychedelic-assisted Addiction Treatment: Participant Accounts and Qualitative Perspectives"


April 12, 2016 - Alexander Belser, PhD (cand.), MPhil, Fellow and Adjunct Instructor in the Department of Applied Psychology, New York University

Title - "Psilocybin-Assisted Psychotherapy and Psychedelically Occasioned Mystical Experiences: A Preview of Recent Findings from NYU"


May 10, 2016 - Frederick Barrett, PhD, Instructor of Psychiatry and Behavioral Sciences, Johns Hopkins University

Title - "Psilocybin, Meditation, Mystical Experiences, and Neuroimaging"


May 19, 2016 - Leor Roseman, PhD (cand.), Division of Brain Sciences, Imperial College London

Title - "Neural Correlates of LSD-Induced, Eyes-Closed, Psychedelic Imagery"

Yale Psychedelic Science Group In the News

Yale Psychedelic Science Group Leadership

Residents and faculty who lead the Yale Psychedelic Science Group are: